These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 13436598)
1. [Skin reactivity in Hodgkin's disease]. SERVI M; PAULUZZI S Boll Ist Sieroter Milan; 1957; 36(1-2):15-21. PubMed ID: 13436598 [No Abstract] [Full Text] [Related]
2. Correlation of active rosette test with reactivity in normals and in patients with Hodgkin's disease. Yalçin B Haematologica; 1980 Oct; 65(5):682-5. PubMed ID: 6780427 [No Abstract] [Full Text] [Related]
3. [In vivo studies, using the skin-window technic, on the inflammatory cellular reactivity in hodgkin's disease]. Maglulo E; Carcò FP; Giraldi M; Sprovieri G Arch De Vecchi Anat Patol; 1967 Dec; 50(3):615-27. PubMed ID: 4951032 [No Abstract] [Full Text] [Related]
4. Anergy and skin homograft survival in Hodgkin's disease. KELLY WD; GOOD RA; VARCO RL Surg Gynecol Obstet; 1958 Nov; 107(5):565-70. PubMed ID: 13592655 [No Abstract] [Full Text] [Related]
5. [Immunoserological research in Hodgkin's disease]. Schächter A; Sărăţeanu D; Cepleanu M; Cajal N; Sorodoc I Med Interna (Bucur); 1966 Nov; 18(11):1359-66. PubMed ID: 6009917 [No Abstract] [Full Text] [Related]
6. Immunophenotyping of Hodgkin's disease--an aid to its classification. Kalyan K; Basu D; Soundararaghavan J Indian J Pathol Microbiol; 2006 Apr; 49(2):173-7. PubMed ID: 16933709 [TBL] [Abstract][Full Text] [Related]
7. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty. Basu D; Roy SK Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719 [TBL] [Abstract][Full Text] [Related]
8. [Immunology of Hodgkin's disease]. Weil M; Jacquillat C Presse Med (1893); 1967 Apr; 75(17):857-8. PubMed ID: 5336431 [No Abstract] [Full Text] [Related]
9. [Immunity reaction in Hodgkin's disease]. FABIANI F Prog Med (Napoli); 1957 Jan; 13(2):57-61. PubMed ID: 13420207 [No Abstract] [Full Text] [Related]
10. Hodgkin's disease is a non-Hodgkin lymphoma. Taylor CR Hum Pathol; 2005 Jan; 36(1):1-4. PubMed ID: 15712174 [No Abstract] [Full Text] [Related]
11. Letter: Chemotactic-factor inactivator in Hodgkin's disease. Saccoccia P N Engl J Med; 1974 Apr; 290(16):913-4. PubMed ID: 4816976 [No Abstract] [Full Text] [Related]
16. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma. Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176 [TBL] [Abstract][Full Text] [Related]
17. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging. Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517 [TBL] [Abstract][Full Text] [Related]
18. [Nephrotic syndrome in Hodgkin's disease]. Miltényi Z; Keresztes K; Ujhelyi L; Kovács J; Illés A Orv Hetil; 2005 Jun; 146(25):1357-60. PubMed ID: 16106759 [TBL] [Abstract][Full Text] [Related]
19. The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma. Enblad G; Molin D; Glimelius I; Fischer M; Nilsson G Hematol Oncol Clin North Am; 2007 Oct; 21(5):805-23. PubMed ID: 17908621 [TBL] [Abstract][Full Text] [Related]
20. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes. Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]